Protocol for the examination of specimens from patients with neuroblastoma and related neuroblastic tumors

Archives of Pathology and Laboratory Medicine

Volumn 129, Issue 7, 2005, Pages 874-883

  Qualman, Stephen J ^a,e   Bowen, Jay ^a   Fitzgibbons, Patrick L ^b   Cohn, Susan L ^c   Shimada, Hiroyuki ^d  

^a NATIONWIDE CHILDREN S HOSPITAL   (United States)

^b ST JUDE MEDICAL CENTER   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d CHILDREN S HOSPITAL LOS ANGELES   (United States)

^e THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOPSY; CELL STRUCTURE; CLINICAL FEATURE; CYTOGENETICS; CYTOLOGY; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; ENDOCRINE FUNCTION; HUMAN; MEDICAL SOCIETY; NEEDLE BIOPSY; NEUROBLASTOMA; ONCOGENE C MYB; PATHOLOGICAL ANATOMY; PLOIDY; PRACTICE GUIDELINE; PROGNOSIS; REVIEW; RISK ASSESSMENT; RISK FACTOR; SERODIAGNOSIS; SURGICAL APPROACH; TISSUE FIXATION; CLASSIFICATION; CLINICAL PROTOCOL; PATHOLOGY;

CLINICAL PROTOCOLS; HUMANS; NEUROBLASTOMA;

EID: 21344458328     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (28)

1. LaQuaglia MP. Surgical management of neuroblastoma. Semin Pediatr Surg. 2001;10:132-139.
2. Wenzel A, Cziepluch C, Hamann U, Schurmann J, Schwab M. The N-Myc oncoprotein is associated in vivo with the phosphoprotein Max (p20/22) in human neuroblastoma cells. EMBO J. 1991;10:3703-3712
3. Shimada H, Stram D, Chatten J, et al. Identification of subsets of neuroblastomas combined with histopathologic and N-myc analysis. J Natl Cancer Inst. 1995;87:1470-1476.
4. Goto S, Umehara S, Gerbing RB, et al. Histopathology and MYCN status in peripheral neuroblastic tumors: a report from the Children's Cancer Group. Cancer. 2001;92:2699-2708.
5. Hook AZ, Hayes FA, Shuster JJ, et al. Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: a Pediatric Oncology Group study. J Clin Oncol. 1991;9:581-591.
6. Abramson SJ, Berdon WE, Ruzal-Shapiro C, Stolar C, Garvin J. Cervical neuroblastoma in eleven infants-a tumor with favorable prognosis: clinical and radiologic (US, ST, MRI) findings. Pediatr Radiol. 1993;23:253-257.
7. Haase GM, O'Leary MC, Stram DO, et al. Pelvic neuroblastoma-implications for a new favorable subgroup: a Children's Cancer Group experience. Ann Surg Oncol. 1995;2:516-523.
8. Russo C, Cohn SL, Petruzzi MJ, et al. Long-term neurologic outcome in children with opsoclonus-myoclonus associated with neuroblastoma: a report from the Pediatric Oncology Group. Med Pediatr Oncol. 1997;28:284-288.
9. Hartman CE, Shochat SJ. Abdominal mass lesions in the newborn: diagnosis and treatment. Clin Perinatol. 1989;16:123-125.
10. Hugosson C, Nyman R, Jorulf H, et al. Imaging of abdominal neuroblastoma in children. Acta Radiol. 1999;40:534-542.
11. Jacobs A, Delree M, Desprechins B, et al. Consolidating the role of *I-MIBG scintigraphy in childhood neuroblastoma: five years of clinical experience. Pediatr Radiol. 1990;20:157-159.
12. Laug WE, Siegel SE, Shaw KN, Landing B, Baptista J, Gutenstein M. Initial urinary catecholamine metabolite concentrations and prognosis in neuroblasto-ma. Pediatrics. 1978;62:77-83.
13. Horsmans Y, Desager JP, Harveugt C. Sensitivity and specificity of the determination of urinary catecholamines and their acid metabolites in the diagnosis of neuroblastoma in children. Bull Cancer. 1990;77:985-989.
14. Scheibel E, Rechnitzer C, Fahrenkrug J, et al. Vasoactive intestinal peptide (VIP) in children with neural crest tumors. Acta Paediatr Scand. 1982;71:721-725.
15. Hann HWL. Serum markers and prognosis in neuroblastoma: Ferritin, LDH, and NSE. In: Brodeur GM, Sawada T, Tsuchida Y, Voute PA, eds. Neuroblastoma. Amsterdam, The Netherlands: Elsevier; 2000:371-381.
16. Hann HW, Evans AW, Siegel SE, et al. Prognostic importance of serum ferritin in patients with stages III and IV neuroblastoma: the Children's Cancer Study Group experience. Cancer Res. 1985;43:2843-2848.
17. Berthold F, Trechow R, Utsch S, et al. Prognostic factors in metastatic neuroblastoma: a multivariate analysis of 182 cases. Am J Pediatr Hematol Oncol. 1992;14:207-215.
18. Zeltzer PM, Maroupos PJ, Sateur H, et al. Prognostic significance of serum neuropeptide specific enolase in local and widespread neuroblastoma. Prog Clin Biol Res. 1985;175:319-329.
19. Shimada H, Ambros IM, Dehner LP, Hata J, Joshi VV, Roald B. Terminology and morphologic criteria of neuroblastic tumors: recommendations by the International Neuroblastoma Pathology Committee. Cancer, 1999;86:349-363.
20. Shimada H, Ambros IM, Dehner LP, et al. The International Neuroblastoma Pathology Classification (the Shimada system). Cancer. 1999;86:364-372.
21. Joshi VV, Cantor AB, Altschuler A, et al. Age-linked prognostic categorization based on a new histologic grading system of neuroblastomas: a clinicopathologic study of 211 cases from the Pediatric Oncology Croup. Cancer, 1992; 69:2197-2211.
22. Joshi VV, Chatten J, Sather HN, Shimada H. Evaluation of the Shimada classification in advanced neuroblastoma with a special reference to the mitosis-karyorrhexis index: a report from the Children's Cancer Study Group. Mod Pathol. 1991;4:139-147.
23. Shimada H, Roald B. Histology: tumors of the neuroblastoma group. In: Brodeur GM, Sawada T, Tsuchida Y, Voute PA, eds. Neuroblastoma. Amsterdam, The Netherlands: Elsevier; 2000:341-354.
24. Shimada H, Chatten J, Newton WA Jr, et al. Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastoma. J Natl Cancer Inst. 1984;73: 405-416.
25. Umenara S, Nakagawa A, Matthay KK, et al. Histopathology defines prognostic subsets of ganglioneuroblastoma, nodular. Cancer. 2000;89:1150-1161.
26. Peuchmaur M, d'Amore ES, Joshi VV, et al. Revision of the International Neuroblastoma Pathology Classification: confirmation of favorable and unfavorable prognostic subsets in ganglioneuroblastoma, nodular. Cancer. 2003;98: 2274-2281.
27. Brodeur GM, Sawada T, Tsuchida Y, Voute PA, eds. Neuroblastoma. Amsterdam, The Netherlands: Elsevier; 2000.
28. O'Dorisio MS, Qualman SJ. Neuroblastoma. In: Mazaferri EM, Samaan NA, eds. Endocrine Tumors. Cambridge, Mass: Blackwell Scientific Publications; 1993: 448-454.